| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |